Literature DB >> 32096049

The Pathophysiology of Tau and Stress Granules in Disease.

Anna Cruz1, Mamta Verma1, Benjamin Wolozin2,3,4.   

Abstract

This chapter discusses the relationship between tau, RNA binding proteins and stress granules, which exhibit an intimate bidirectional relationship affecting the functions of both tau and the translational stress response. We describe how tau becomes hyperphosphorylated and oligomerized as part of an endogenous mechanism to promote the translational stress response through interaction with RNA binding proteins. Prior studies demonstrate that dysfunction of RNA binding proteins biology is sufficient to cause neurodegenerative diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia. Emerging evidence indicates that tau-mediated neurodegeneration also occurs through a mechanism that is mediated by RNA binding proteins and the translational stress response. Discovery of the role of RNA metabolism in tauopathy opens a wide variety of novel therapeutic approaches. Multiple studies have already shown that approaches reducing the levels of selected RNA binding proteins or inhibiting the translational stress response can intervene in the pathophysiology of motoneuron diseases. Emerging studies show that reducing the levels of selected RNA binding proteins or inhibiting the translational stress response also reduces neurodegeneration in models of tauopathy and Aβ mediated degeneration. The combined impact of these studies indicate that RNA binding proteins and RNA metabolism represent a valuable new frontier for the investigation and treatment tauopathies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 32096049      PMCID: PMC8265570          DOI: 10.1007/978-981-32-9358-8_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  96 in total

1.  Sustained translational repression by eIF2α-P mediates prion neurodegeneration.

Authors:  Julie A Moreno; Helois Radford; Diego Peretti; Joern R Steinert; Nicholas Verity; Maria Guerra Martin; Mark Halliday; Jason Morgan; David Dinsdale; Catherine A Ortori; David A Barrett; Pavel Tsaytler; Anne Bertolotti; Anne E Willis; Martin Bushell; Giovanna R Mallucci
Journal:  Nature       Date:  2012-05-06       Impact factor: 49.962

2.  A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation.

Authors:  Avinash Patel; Hyun O Lee; Louise Jawerth; Shovamayee Maharana; Marcus Jahnel; Marco Y Hein; Stoyno Stoynov; Julia Mahamid; Shambaditya Saha; Titus M Franzmann; Andrej Pozniakovski; Ina Poser; Nicola Maghelli; Loic A Royer; Martin Weigert; Eugene W Myers; Stephan Grill; David Drechsel; Anthony A Hyman; Simon Alberti
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

3.  The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.

Authors:  D H Geschwind; S Perlman; C P Figueroa; L J Treiman; S M Pulst
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.

Authors:  Mychael V Lourenco; Julia R Clarke; Rudimar L Frozza; Theresa R Bomfim; Letícia Forny-Germano; André F Batista; Luciana B Sathler; Jordano Brito-Moreira; Olavo B Amaral; Cesar A Silva; Léo Freitas-Correa; Sheila Espírito-Santo; Paula Campello-Costa; Jean-Christophe Houzel; William L Klein; Christian Holscher; José B Carvalheira; Aristobolo M Silva; Lício A Velloso; Douglas P Munoz; Sergio T Ferreira; Fernanda G De Felice
Journal:  Cell Metab       Date:  2013-12-03       Impact factor: 27.287

5.  Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.

Authors:  Lin Guo; Hong Joo Kim; Hejia Wang; John Monaghan; Fernande Freyermuth; Julie C Sung; Kevin O'Donovan; Charlotte M Fare; Zamia Diaz; Nikita Singh; Zi Chao Zhang; Maura Coughlin; Elizabeth A Sweeny; Morgan E DeSantis; Meredith E Jackrel; Christopher B Rodell; Jason A Burdick; Oliver D King; Aaron D Gitler; Clotilde Lagier-Tourenne; Udai Bhan Pandey; Yuh Min Chook; J Paul Taylor; James Shorter
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

6.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

7.  Uncoupling stress granule assembly and translation initiation inhibition.

Authors:  Sophie Mokas; John R Mills; Cristina Garreau; Marie-Josée Fournier; Francis Robert; Prabhat Arya; Randal J Kaufman; Jerry Pelletier; Rachid Mazroui
Journal:  Mol Biol Cell       Date:  2009-04-15       Impact factor: 4.138

8.  Tau Activates Transposable Elements in Alzheimer's Disease.

Authors:  Caiwei Guo; Hyun-Hwan Jeong; Yi-Chen Hsieh; Hans-Ulrich Klein; David A Bennett; Philip L De Jager; Zhandong Liu; Joshua M Shulman
Journal:  Cell Rep       Date:  2018-06-05       Impact factor: 9.423

9.  Dysregulation of RNA Splicing in Tauopathies.

Authors:  Daniel J Apicco; Cheng Zhang; Brandon Maziuk; Lulu Jiang; Heather I Ballance; Samantha Boudeau; Choong Ung; Hu Li; Benjamin Wolozin
Journal:  Cell Rep       Date:  2019-12-24       Impact factor: 9.423

10.  Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits.

Authors:  Tao Ma; Mimi A Trinh; Alyse J Wexler; Clarisse Bourbon; Evelina Gatti; Philippe Pierre; Douglas R Cavener; Eric Klann
Journal:  Nat Neurosci       Date:  2013-08-11       Impact factor: 24.884

View more
  10 in total

Review 1.  The Structure Biology of Tau and Clue for Aggregation Inhibitor Design.

Authors:  Dan Wang; Xianlong Huang; Lu Yan; Luoqi Zhou; Chang Yan; Jinhu Wu; Zhengding Su; Yongqi Huang
Journal:  Protein J       Date:  2021-08-17       Impact factor: 2.371

Review 2.  Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies.

Authors:  Shon A Koren; Sara Galvis-Escobar; Jose F Abisambra
Journal:  Neurobiol Dis       Date:  2020-05-12       Impact factor: 5.996

3.  Interplay between tau and α-synuclein liquid-liquid phase separation.

Authors:  Anna Siegert; Marija Rankovic; Filippo Favretto; Tina Ukmar-Godec; Timo Strohäker; Stefan Becker; Markus Zweckstetter
Journal:  Protein Sci       Date:  2021-01-28       Impact factor: 6.725

4.  Liquid-liquid phase separation induces pathogenic tau conformations in vitro.

Authors:  Nicholas M Kanaan; Chelsey Hamel; Tessa Grabinski; Benjamin Combs
Journal:  Nat Commun       Date:  2020-06-04       Impact factor: 14.919

Review 5.  Chinese nutraceuticals and physical activity; their role in neurodegenerative tauopathies.

Authors:  Abdullahi Alausa; Sunday Ogundepo; Barakat Olaleke; Rofiat Adeyemi; Mercy Olatinwo; Aminat Ismail
Journal:  Chin Med       Date:  2021-01-06       Impact factor: 5.455

Review 6.  Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies.

Authors:  M Catarina Silva; Stephen J Haggarty
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

Review 7.  Transcription Regulators and Membraneless Organelles Challenges to Investigate Them.

Authors:  Katarzyna Sołtys; Andrzej Ożyhar
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

Review 8.  Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey.

Authors:  Paulo J da Costa; Malika Hamdane; Luc Buée; Franck Martin
Journal:  Biomedicines       Date:  2022-01-23

Review 9.  Pathophysiology of stress granules: An emerging link to diseases (Review).

Authors:  Jihui Wang; Yixia Gan; Jian Cao; Xuefen Dong; Wei Ouyang
Journal:  Int J Mol Med       Date:  2022-02-09       Impact factor: 4.101

10.  Stress Granules in Cancer.

Authors:  Min-Seok Song; Elda Grabocka
Journal:  Rev Physiol Biochem Pharmacol       Date:  2020-08-14       Impact factor: 5.545

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.